Calendrier des promotions ESSA Pharma Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise ESSA Pharma Inc.
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. The company develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. It has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.Paramètres de base
IPO date
2015-07-09
ISIN
CA29668H7085
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 0 | 0 |
| P/BV | 2.19 | 7 |
| P/E | 0 | 0 |
Efficacité
| Nom | Signification | Grade |
| ROA | -20.59 | 0 |
| ROE | -20.85 | 0 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | -0.0124 | 10 |
| Debt/Ratio | 0.0026 | 10 |
| Debt/Equity | 0.0281 | 10 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 0 | 0 |
| Rentabilité Ebitda, % | 118.64 | 10 |
| Rentabilité EPS, % | -38.02 | 0 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 1.61 $ | 0 $ | 0 $ | 4.97 % | 0 % | 0 % |
| common.calendar.number_days.7d | 1.66 $ | 0 $ | 0 $ | 1.81 % | 0 % | 0 % |
| common.calendar.number_days.30d | 1.79 $ | 1.61 $ | 1.72 $ | -5.59 % | 0 % | 0 % |
| common.calendar.number_days.90d | 1.7 $ | 1.44 $ | 1.82 $ | -0.59 % | 0 % | 0 % |
| common.calendar.number_days.180d | 1.79 $ | 1.44 $ | 1.92 $ | -5.59 % | 0 % | 0 % |
| common.calendar.number_days.1y | 6.27 $ | 1.4 $ | 7.1 $ | -73.05 % | 0 % | 0 % |
| common.calendar.number_days.3y | 5.67 $ | 1.4 $ | 10.65 $ | -70.19 % | 0 % | 0 % |
| common.calendar.number_days.5y | 4.5 $ | 1.4 $ | 34.28 $ | -62.44 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 $ | 0.16 $ | 34.28 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 1.61 $ | 1.44 $ | 1.92 $ | 4.97 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Dr. David Ross Parkinson M.D. | President, CEO & Director | 814.15k | 1950 (75 années) |
| Mr. David S. Wood C.M.A., CPA, CMA, CPA, M.B.A., MBA | Chief Financial Officer | 590.39k | 1957 (68 années) |
| Mr. Peter A. Virsik M.B.A., M.S. | Executive VP & COO | 645.95k | 1971 (54 année) |
| Dr. Alessandra Cesano M.D., Ph.D. | Chief Medical Officer & Executive VP | 623.93k | 1961 (64 année) |
| Chandtip Chandhasin | Executive | N/A | |
| Erica Osbourne | Executive | N/A | |
| Erin Rudsinski | Executive | N/A | |
| Loleta Harris | Executive | N/A | |
| Neil Thapar | Executive | N/A | |
| Nkengyal Barber | Executive | N/A |
Informations sur l'entreprise
Adresse: Canada, Vancouver. BC VZ K, 999 West Broadway - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.essapharma.com
Site web: https://www.essapharma.com
